Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
UCBJF:OTCMKTS
UCB SA
$296.54
+5.93%
(+16.59) 1D
Apr 23, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UCBJF...
Open
$296.54
High
$296.54
Low
$296.54
Mkt. cap
46.93B
Avg. vol.
883.00
Volume
33.00
52-wk high
$345.39
52-wk low
$168.65
Beta
0.75
Shares outstanding
194.51M
No. of employees
10K
News stories
From sources across the web
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology. Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA
CEOJean-Christophe Tellier
Employees9.76K
FoundedJan 18, 1928
Headquarters-
SectorPharmaceutical industry
Websiteucb.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.74B
1.74B
2.13B
2.13B
Cost of goods sold
461.00M
461.00M
534.00M
534.00M
Cost of revenue
461.00M
461.00M
534.00M
534.00M
Research and development expenses
430.00M
430.00M
481.00M
481.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639.00M
639.00M
735.50M
735.50M
Operating expense
935.50M
935.50M
946.50M
946.50M
Total operating expenses
1.40B
1.40B
1.48B
1.48B
Operating income
347.00M
347.00M
646.50M
646.50M
Other non operating income
-40.50M
-40.50M
36.00M
36.00M
EBT including unusual items
296.50M
296.50M
614.50M
614.50M
EBT excluding unusual items
308.00M
308.00M
622.50M
622.50M
Income tax expense
59.00M
59.00M
73.00M
73.00M
Effective tax rate
19.90%
19.90%
11.88%
11.88%
Other operating expenses
-133.50M
-133.50M
-270.00M
-270.00M
Net income
237.50M
237.50M
541.50M
541.50M
Net profit margin
13.62%
13.62%
25.46%
25.46%
Earnings per share
-
-
-
-
Interest and investment income
40.00M
40.00M
-
-
Interest expense
-21.50M
-21.50M
-58.00M
-58.00M
Net interest expenses
18.50M
18.50M
-58.00M
-58.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
503.50M
503.50M
803.50M
803.50M
Gain or loss from assets sale
-
-
1.00M
1.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer